Search
for

    Sort by

    Research 691–720 of 1000+

    1. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    2. Ashwagandha root in the treatment of non-classical adrenal hyperplasia BMJ case reports · 2012 · 5 citations
    3. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    4. Contrast-Enhanced Ultrasound (CEUS) Evaluation of Canine Prostatic Hyperplasia before and after Osaterone Acetate Therapy: Preliminary Results Animals · 2024 · 4 citations
    5. Challenges in treatment of patients with non-classic congenital adrenal hyperplasia Frontiers in Endocrinology · 2022 · 4 citations
    6. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    7. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    8. Mitigating Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Ameliorating Sexual Function and Psychological Well-Being in Older Men American Journal of Men s Health · 2023 · 3 citations
    9. Measuring steroids in hair opens up possibilities to identify congenital adrenal hyperplasia in developing countries Clinical endocrinology · 2022 · 3 citations
    10. Diagnostic imaging in congenital adrenal hyperplasia – how does it help? Clinical endocrinology and metabolism journal · 2020 · 3 citations
    11. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia The Journal of Urology · 2020 · 3 citations
    12. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    13. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    14. Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD) Journal of Steroid Biochemistry · 1990 · 3 citations
    15. Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus · 2025 · 2 citations
    16. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    17. Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia JCEM Case Reports · 2024 · 2 citations
    18. Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases The World Journal of Men s Health · 2024 · 2 citations
    19. Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature Frontiers in genetics · 2022 · 2 citations
    20. Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia Acta Cardiologica · 2019 · 2 citations
    21. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    22. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II Mayo Clinic Proceedings · 2006 · 2 citations
    23. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    24. Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats. PubMed · 2024 · 1 citations
    25. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    26. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study Scientific Reports · 2023 · 1 citations
    27. PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia Journal of the Endocrine Society · 2022 · 1 citations
    28. 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study British Journal of Clinical Pharmacology · 2022 · 1 citations
    29. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism Case reports in endocrinology · 2022 · 1 citations
    30. Inhibition of Proliferation of LNCaP Prostate Cells by Corni Fructus Extract Is Associated with a Decrease in the Expression of Benign Prostatic Hyperplasia-Causing Factors Journal of Korean Medicine for Obesity Research · 2021 · 1 citations